期刊文献+

1例急性心肌梗死合并肺部感染患者的药学监护 被引量:3

Pharmaceutical Care for One Case of Acute Myocardial Infarction Complicated with Pulmonary Infection
原文传递
导出
摘要 目的:探讨临床药师在急性心肌梗死患者治疗过程中发挥的作用。方法:临床药师对1例急性心肌梗死患者实行药学监护,对药物相互作用、药物不良反应等进行分析识别,对抗感染治疗方案提出建议,评估出血倾向与栓塞风险并存时的治疗矛盾,提出合理的处置方案。结果:在临床药师的参与下,患者接受合理有效的治疗后病情好转出院。结论:临床药师参与临床诊治可提高药物治疗的有效性与安全性。 Objective: To explore the role of clinical pharmacist played in treating patients with acute myocardial infarction. Methods: The clinical pharmacists participated in the therapy for a patient with acute myocardial infarction and provided individual pharmaceutical care. The clinical pharmacist optimized the therapy by means of recognizing the drug-drug interactions and adverse drug reactions as well as evaluating the risk of thrombosis versus bleeding for the patient. Results: The therapeutic suggestions of the clinical pharmacist were accepted by the physicians. The patient was treated effectively and discharged from hospital. Conclusion: Clinical pharmacist can provide beneficial contributions to safe, effective and optimal medication.
出处 《中国药师》 CAS 2016年第2期327-329,共3页 China Pharmacist
基金 浙江省医药卫生科技计划项目(编号:2015KYB374)
关键词 临床药师 急性心肌梗死 肺部感染 Clinical pharmacist Acute myocardial infarction Pulmonary infection
  • 相关文献

参考文献9

  • 1Nash MC, Strom JA, Pathak EB. Prevalence of major infections and adverse outcomes among hospitalized. ST-elevation myocardial infarc- tion patients in Florida [ J ]. Bmc Cardiovascular Disorders, 2011, 11 (21) :69-77.
  • 2肖永红.产NDM-1泛耐药肠杆菌科细菌感染抗菌治疗[J].中国新药杂志,2011,20(3):219-223. 被引量:6
  • 3Elemam A, Rahimian J, Mandell W. Infection with panresistant Klebsiella pneumoniae : a report of 2 cases and a brief review of the literature [ J ]. Clinical infectious diseases, 2009, 49 ( 2 ) : 271-274.
  • 4Daikos GL, Mark6giannakis A. Carbapenemase-producing Klebsiella pneu- -moniae:(when) might we still consider treating with carbap- enems? [J]. Clinical Microbiology and Infection, 2011, 17 (8): 1135-1141.
  • 5贾荣娣,史红军.84例头孢哌酮/舒巴坦不良反应报告分析[J].药物流行病学杂志,2010,19(7):390-392. 被引量:4
  • 6Alagozlu H, Cindoruk M, Unal S. Severe INR elevation in a patient with choledocholithiasis receiving cefoperazone [ J ]. Clinical drug in- vestigation, 2006, 26(8):481-484.
  • 7Ph Gabriel S, James SK, Dan A, et al. ESC Guidelines for the man- agement of aeute myocardial infarction in patients presenting with ST- segment elevation [ J ]. European Heart Journal, 2012, 33 ( 20 ) : 53- 53.
  • 8Jack A, Jack H, Elaine H, et al. Pharmacology and Management of the Vitamin K AntagonistsAmerican College of Chest Physicians Evi- dence-Based Clinical Practice Guidelines (8th Edition) [ J]. Chest Journal, 2008, 133(3) :160S-198S.
  • 9韩静静,徐亚青,何宇红,宋金春,吴凡,成于珈.急性冠脉综合征患者药学监护探讨[J].中国药师,2013,16(12):1896-1898. 被引量:5

二级参考文献13

  • 1梁小岩,雷桂华,曾伟强,侯淳.输液不良反应原因的系统分析与控制对策[J].中国医院药学杂志,2006,26(1):111-113. 被引量:69
  • 2邓晟,尹桃,杨芝春,倪渊.国内外加替沙星不良反应病例报道浅析[J].中国药物警戒,2006,3(5):267-270. 被引量:26
  • 3Hamm CW, Bassand JP, Agewall S, et al.ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation[J].European Heart Journal,2011,32:2999-3054.
  • 4Jeffrey LA, Cynthia DA, Elliott MA,et al. 2011ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction:A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines [J]. Circulation, 2011,123:2022-2060.
  • 5Bhatt DL,Scheiman J,Abraham NS,et al.ACCF/ACG/ AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use:a report of the American College of Cardiology FoundationTask Force on Clinical Expert Consensus Documents[J].Circulation,2008,118(18):1894-1909.
  • 6Michelle L,Eugene B,Elliott MA,et al.Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor:an analysis of two randomised trials[J]. Lancet,2009,374(9694):989-997.
  • 7Ho PM, Maddox TM, Wang L,et al. Risk of Adverse Outcomes Associated With Cloncomitant Use of Clopidogrel and Proton Pump Inhibitors Following Acute Coronary Sydrome[J]. JAMA,2009,301(9):937-944.
  • 8史红军.2006年我院115例药品不良反应报告分析[J].药物流行病学杂志,2008,17(4):246-249. 被引量:5
  • 9吴连平,周明,史红军.我院2007年药品不良反应报告分析[J].中国药业,2009,18(14):55-56. 被引量:6
  • 10秦晓华,杨帆.急性病医疗机构耐碳青霉烯类抗生素或产碳青霉烯酶肠杆科细菌感染的诊治指南[J].中国感染与化疗杂志,2009,9(5):400-400. 被引量:9

共引文献12

同被引文献24

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部